Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis To Test Dengue Fever Vaccine In Singapore, Vietnam

This article was originally published in PharmAsia News

Executive Summary

France's Sanofi-Aventis says it will expand its clinical trials for a dengue fever vaccine to Singapore and Vietnam as it attempts to get regulatory approval as soon as 2015. The company's vaccine arm, Sanofi Pasteur, already has trials underway in Thailand and the Philippines. The sometimes-fatal disease affects two million people a year, mostly in developing countries. The Sanofi vaccine would be the first for dengue fever if approved. (Click here for more
Advertisement

Related Content

Novartis Head of Corporate Research And Chairman, Novartis Institute For Tropical Diseases, Paul Herrling On The Need For Government Funding For Neglected Diseases: An Interview With PharmAsia News
Advertisement
UsernamePublicRestriction

Register

SC071421

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel